While CD39 is highly expressed on tumor infiltrating immune cells—particularly Tregs, effector T cells, and myeloid cells—like CD73, it is also often expressed on tumor-associated endothelium as well as tumor cells themselves [20, 43–46]. The gene discussed is NT5E; the disease is neoplasm.